37 indicted in East Coast drug ‘pipeline’; many from Albany, Schenectady
BREAKING: 37 indicted in East Coast drug ‘pipeline’; many from Albany, Schenectady June 15, 2011 Updated 1:24 p.m. Photographer: Stacey Lauren-Kennedy “Operation Pipeline” led to 37 indictments today in Albany.
Go here to see the original:
37 indicted in East Coast drug ‘pipeline’; many from Albany, Schenectady
Fitch: DCP Midstream, LLC’s Seaway Acquisition Will Have No Immediate Impact on Ratings
NEW YORK–(BUSINESS WIRE)–Fitch Ratings believes DCP Midstream, LLC’s (DCP; IDR: ‘BBB’, Stable Outlook) announced acquisition of the Seaway pipeline from Conoco Philips will have no immediate impact on the company’s ratings. DCP announced an agreement to acquire the pipeline and convert it from a refined products pipeline to a natural gas liquids (NGLs) pipeline running from Conway, Kansas to Mont Belvieu, Texas. The conversion will include two extensions and the addition of pump capacity and g
Originally posted here:
Fitch: DCP Midstream, LLC’s Seaway Acquisition Will Have No Immediate Impact on Ratings
2011 Spinoff Report Pipeline Grows to a Record $750bn
NEW YORK & LONDON–(BUSINESS WIRE)–2011 Spinoff Report Pipeline Grows to a Record $750bn. Record 100 Spinoffs. www.SpinoffReport.com
View original post here:
2011 Spinoff Report Pipeline Grows to a Record $750bn
Wohl & Fruchter Initiates Investigation into El Paso Pipeline Partners’ Purchase of Southern Natural Gas Co. Interest from El Paso Corp.
NEW YORK–(BUSINESS WIRE)–Wohl & Fruchter LLP has commenced an investigation into the related-party purchase of a 25% interest in Southern Natural Gas Co. by El Paso Pipeline Partners LP from El Paso Corporation.
Originally posted here:
Wohl & Fruchter Initiates Investigation into El Paso Pipeline Partners’ Purchase of Southern Natural Gas Co. Interest from El Paso Corp.
Fitch Affirms Williams Cos. And Williams Partners Following Announced Spin-Off
NEW YORK–(BUSINESS WIRE)–Fitch Ratings has affirmed the Issuer Default Ratings (IDRs) and senior debt ratings for The Williams Companies, Inc. (WMB) and Williams Partners L.P. (WPZ) at ‘BBB-’ following today’s announced planned spin-off of WMB’s exploration and production (E&P) operations. Also affirmed are ratings for WPZ affiliates, Williams Partners Finance Corporation (WPFC), Northwest Pipeline GP (NWP), and Transcontinental Gas Pipeline Company, LLC (TGPL). A full list of rated entiti
Visit link:
Fitch Affirms Williams Cos. And Williams Partners Following Announced Spin-Off
Fitch Affirms San Luis Obispo County Fin Auth at ‘AA-’; Outlook Stable
SAN FRANCISCO–(BUSINESS WIRE)–Fitch Ratings has affirmed its ‘AA-’ rating on the following San Luis Obispo County Financing Authority, CA, debt as part of its continuous surveillance effort: –$157.8 million Nacimiento Water Pipeline Project revenue bonds, series 2007A (tax-exempt); –$37.5 million Nacimiento Water Pipeline Project revenue bonds, series 2007B (taxable). The Rating Outlook is Stable. RATING RATIONALE: –Debt service is supported by take-or-pay water delivery entitlement contrac
Follow this link:
Fitch Affirms San Luis Obispo County Fin Auth at ‘AA-’; Outlook Stable
Fitch: Global Pharma R&D Hit Some Bumps in 2Q’10 but Approval Trends Remain Positive for 2010
LONDON & CHICAGO–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) approved seven new molecular entities (NMEs) and biological pharmaceuticals during the second quarter of 2010 (2Q’10), according to Fitch Ratings’ new Global Pharmaceutical R&D Pipeline report, in a virtual repeat of the first quarter. In the European Union, the European Medicines Agency (EMEA) cleared three NMEs, including Prolia, which was also approved in the U.S. Six of these NMEs were developed by pharmaceuti
Read the original post:
Fitch: Global Pharma R&D Hit Some Bumps in 2Q’10 but Approval Trends Remain Positive for 2010
Research and Markets: SkyePharma Plc-Detailed Product Pipeline
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/94b25c/skyepharma_plcdet) has announced the addition of the “SkyePharma Plc-Detailed Product Pipeline” company profile to their offering. SkyePharma Plc-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope of the reports Each Pipeline
Read more:
Research and Markets: SkyePharma Plc-Detailed Product Pipeline
75+ Portland Weekend Event, Parties & Free Tickets | September 9-12
75+ Portland Weekend Event, Parties & Free Tickets | September 9-12 — Thu Sep 09 08:53:28 UTC 2010 Leigh sent out his weekly email of Portland weekend events earlier today. It is mostly reproduced below with some additions by Pipeline. You can get the email and your chance to win hookups for shows and deals by emailing leighfeldman3 @ gmail and aski… about: Adam Chelsea Lately comedian Devin Philips (Fri) Director of E-Diplomacy events Facebook Group football Free From Pipeline Greg Proops Halloween Helium Comedy Club Hollywood Theater From Pipeline hop! Hospitality Recreation http://wwwmediafirecom/?jzmkyolwd5z# Leigh Feldman Leigh Feldman Portland Lif Major Menomena music MusicFest NW Festival From Pipeline National Football League pdxpipeline events portland events Portland From Pipeline Portland TBA Festival From Pipeline Richard Boly Ringlers Pub Roseland Rufus Wainwright With Oregon Rufus Wainwright With Oregon Symphony Rusty Lazer Slabtown Someday Lounge Tanker Bar Tribute Art Gallery Whose Line Is It Anyway? Wiz Khalifa at: Rotture Slabtown Someday Lounge Rontoms Paris Theater Kenton Park Q Center Roseland Theater Tanker Bar Multnomah Arts Center Jupiter Hotel Disjecta Oregon Symphony Hollywood Theater Beulahland XV Cathedral Park East Burn Motokitty Ringlers Pub Fifth Quadrant
See the original post:
75+ Portland Weekend Event, Parties & Free Tickets | September 9-12
Research and Markets: Hyper pigmentation Therapy Area Pipeline Report 2010 Provides Insight into the Pipeline Status of Hyper Pigmentation Drugs
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/ab8735/hyper_pigmentation) has announced the addition of the “Hyper pigmentation Therapy Area Pipeline Report” report to their offering. Life Science Analytics’, Hyper pigmentation Therapy Area Pipeline Report contains detailed information on the hyper pigmentation drug pipeline. This report provides insight into the pipeline status of hyper pigmentation drugs by company and by stage as well as a summary of
See the article here:
Research and Markets: Hyper pigmentation Therapy Area Pipeline Report 2010 Provides Insight into the Pipeline Status of Hyper Pigmentation Drugs
